Financial Data and Key Metrics Changes - Total revenue for the third quarter reached $225 million, reflecting a 60.6% sequential increase [2][8] - Operating income was $43.5 million, and net income was $37.3 million, a significant improvement from an operating loss of $1.2 million and a net loss of $9.5 million in the same period last year [9] - Adjusted EBITDA for the third quarter was $80.1 million, compared to $1.2 million in the same period last year [9] Business Line Data and Key Metrics Changes - Revenue from the Bitcoin mining business was $220.9 million, with 1,930.8 Bitcoins mined, representing a 50.9% and 37.5% increase respectively on a sequential basis [8] - The used car export platform, AutoCango, generated revenue of $3.3 million, up 90% sequentially [7] Market Data and Key Metrics Changes - The company operates a deployed hash rate of 50 exahash globally, with an average operating hash rate increasing from 40.91 exahash in July to 46.09 exahash in October [3] - The average cost to mine Bitcoins was $81,072 per coin, with oil costs at $99,383 per coin [8] Company Strategy and Development Direction - The company aims to build a global distributed AI compute network powered by green energy, using Bitcoin mining as a stepping stone towards energy and compute ambitions [4][5] - The strategy includes a focus on hash rate optimization over expansion, refreshing older mining models to improve efficiency [3] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the volatile market environment with significant fluctuations in Bitcoin prices and emphasized a flexible approach to manage market risks [4] - The company is committed to enhancing operational efficiency and maintaining a strong balance sheet through strategic debt management [18] Other Important Information - The company has transitioned to a direct listing on the NYSE to enhance transparency and reduce shareholder transaction costs [6] - Clean energy projects in Oman and Indonesia are underway, expected to support future AI infrastructure development [5] Q&A Session Summary Question: Will the company consider selling Bitcoin holdings to fund new business expansion? - Management confirmed a mining holding strategy, retaining all mined Bitcoin as part of a strategic reserve, while remaining flexible in financing options [13] Question: What are the main factors behind the gap between operational hash rate and deployed hash rate? - Management explained that temporary downtime during integration and external factors like extreme weather affected uptime, but operational efficiency has stabilized above 90% [14] Question: Can you elaborate on the financial benefits of converting short-term debt into long-term debt? - The shift enhances balance sheet stability and aligns with the strategy of building Bitcoin reserves through self-mining, with borrowing costs expected to remain stable at 7%-8% [18] Question: How does the company view the risk of AI CapEx entering bubble territory? - Management believes that while the market is reassessing AI investments, long-term compute demand remains strong, and the company will monitor investments closely to optimize capital efficiency [19] Question: How does the recent pullback in Bitcoin affect operating pace for Q4 and 2026? - Management conducts internal stress tests and can adjust operations dynamically under extreme market conditions, maintaining flexibility in BTC holding strategy [22][23] Question: Does owning the Joder site contradict the asset-light model? - Management clarified that the acquisition aligns with long-term needs for low-cost power and infrastructure capabilities, with a balanced approach of leasing and selective acquisitions for future expansion [24]

Financial Data and Key Metrics Changes - Total revenue for the third quarter reached $225 million, representing a sequential increase of 60.6% [2][8] - Operating income was $43.5 million, and net income was $37.3 million, a significant improvement from an operating loss of $1.2 million and a net loss of $9.5 million in the same period last year [9] - Adjusted EBITDA for the third quarter was $80.1 million, compared to $1.2 million in the same period last year [9] Business Line Data and Key Metrics Changes - Revenue from the Bitcoin mining business was $220.9 million, with 1,930.8 Bitcoins mined, reflecting increases of 50.9% and 37.5% respectively on a sequential basis [8] - The used car export platform, AutoCango, generated revenue of $3.3 million, up 90% sequentially [7] Market Data and Key Metrics Changes - The company operates a deployed hash rate of 50 exahash globally, with an average operating hash rate improving from 40.91 exahash in July to 46.09 exahash in October [3] - The average cost to mine Bitcoins was $81,072 per coin, with oil costs at $99,383 per coin [8] Company Strategy and Development Direction - The company aims to build a global distributed AI compute network powered by green energy, using Bitcoin mining as a stepping stone towards energy and compute ambitions [4] - The strategy emphasizes hash rate optimization over expansion, with a focus on refreshing older mining models to improve efficiency [3] - The company is pursuing a balanced model of leasing and selective strategic acquisitions to maintain cost advantages and support its transition [24][25] Management's Comments on Operating Environment and Future Outlook - The current market environment is volatile, with significant fluctuations in Bitcoin prices, but the company is closely monitoring these dynamics [4] - Management believes the fundamental thesis for Bitcoin as a core reserve asset remains intact despite market volatility [13] - The company is taking a differentiated approach in AI compute, focusing on flexible distributed compute units rather than large centralized data centers [5][28] Other Important Information - The company has assembled a new leadership team with experience in digital infrastructure and finance, and transitioned to a direct listing on the NYSE to enhance transparency [6] - Clean energy projects in Oman and Indonesia are underway and expected to be commissioned within the next one to two years [5] Q&A Session Summary Question: Will the company consider selling Bitcoin holdings to fund new business expansion or manage market risk? - The company continues to follow a mining holding strategy, retaining all mined Bitcoin as part of its strategic reserve, while being flexible across financing channels to support new initiatives [13] Question: What are the main factors behind the gap between operational hash rate and deployed hash rate? - Temporary downtime during the integration phase and external factors like extreme weather affected miner availability, but uptime has stabilized above 90% [14] Question: Can you elaborate on the financial benefits of converting short-term debt into long-term debt? - This shift enhances balance sheet stability and reduces financial risk, with borrowing costs expected to remain in the 7%-8% range [18] Question: How does the company view the risk of AI CapEx entering bubble territory? - The company is monitoring AI project investments and adjusting strategies to optimize capital efficiency while avoiding high leverage [19] Question: How does the recent pullback in Bitcoin affect operating pace for Q4 and 2026? - The company conducts internal stress tests and can dynamically adjust operations under extreme scenarios to control expenses [22][23] Question: Does the self-owned Joder site contradict the asset-light model? - The acquisition aligns with long-term needs for low-cost power and stability, and the company will continue to prioritize leasing for rapid expansion [24]

Financial Data and Key Metrics Changes - Total revenue for Q3 2025 reached $225 million, representing a 60.6% increase sequentially [2][8] - Operating income was $43.5 million, and net income was $37.3 million, compared to an operating loss of $1.2 million and a net loss of $9.5 million in the same period last year [9][10] - Adjusted EBITDA for Q3 2025 was $80.1 million, up from $1.2 million in the same period last year [9] Business Line Data and Key Metrics Changes - Revenue from the Bitcoin mining business was $220.9 million, with 1,930.8 Bitcoins mined, reflecting increases of 50.9% and 37.5% respectively on a sequential basis [8] - Revenue from the automotive training business, AutoCango, was $3.3 million, up 90% sequentially [6] Market Data and Key Metrics Changes - The company operates a deployed hash rate of 50 exahash globally, with an average operating hash rate improving from 40.91 exahash in July to 46.09 exahash in October [3][4] - The average cost to mine Bitcoins was $81,072 per coin, with oil costs at $99,383 per coin [8] Company Strategy and Development Direction - The company is focused on building a global distributed AI compute network powered by green energy, using Bitcoin mining as a practical on-ramp towards energy and compute ambitions [4][5] - The strategy prioritizes hash rate optimization over expansion, with upgrades to more energy-efficient mining models [3] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the volatile market environment with significant fluctuations in Bitcoin prices and emphasized the importance of monitoring these dynamics [4] - The company plans to maintain a flexible approach across various financing channels to support new initiatives while retaining all mined Bitcoin as part of its strategic reserve [13] Other Important Information - The company has transitioned to a direct listing on the NYSE to enhance transparency and reduce shareholder transaction costs [5] - A new leadership team with experience in digital infrastructure and finance has been assembled [5] Q&A Session Summary Question: Will the company consider selling Bitcoin holdings to fund new business expansion? - Management confirmed that they will continue to follow a mining holding strategy, retaining all mined Bitcoin as part of their strategic reserve [13] Question: What are the main factors behind the gap between operational hash rate and deployed hash rate? - Management explained that temporary downtime was due to machine relocations and power system commissioning, but uptime has stabilized above 90% [14] Question: Can you elaborate on the financial benefits of converting short-term debt into long-term debt? - Management stated that this shift enhances balance sheet stability and reduces financial risk, with borrowing costs expected to remain in the 7%-8% range [18] Question: How does the recent pullback in Bitcoin affect operating pace for Q4 and 2026? - Management indicated that they conduct internal stress tests and can adjust operations dynamically under extreme market conditions [22] Question: Does the acquisition of the Joder site contradict the asset-light model? - Management clarified that the acquisition aligns with long-term needs for low-cost power and stability, and they will continue a balanced model of lease-first with selective acquisitions [23]

Financial Data and Key Metrics Changes - Revenue for fiscal year 2025 increased by 13% to $79.2 million, while total revenue for the fourth quarter decreased by 6% to $17.5 million [4][10] - Adjusted EBITDA grew by 8%, and adjusted EPS also increased by 8% for the fiscal year [4] - Total gross margin for the fiscal year was 58%, down from 62% in the prior year, with software gross margin at 79% and services gross margin at 30% [13][15] Business Line Data and Key Metrics Changes - Software revenue decreased by 9% in Q4, representing 52% of total revenue, while services revenue decreased by 3%, representing 48% [10] - For the fiscal year, software revenue increased by 12%, accounting for 58% of total revenue, and services revenue increased by 15%, representing 42% [10] - Specific product performance: ADMET Predictor declined by 10% in Q4 but grew by 5% for the fiscal year; GastroPlus declined by 3% in Q4 but grew by 1% for the fiscal year; MonolixSuite grew by 3% in Q4 and 14% for the fiscal year [11] Market Data and Key Metrics Changes - The external environment remained challenging, with client budgets pressured by pharmaceutical headwinds, including tariffs and pricing implementations [4] - Early signs of stabilization were noted as large pharma gained clearer visibility into pricing frameworks and biotech funding improved modestly [5][6] Company Strategy and Development Direction - The company completed a strategic reset, transitioning to a unified operating model to enhance client focus and operational efficiency [4] - The strategy includes building an integrated product ecosystem that combines validated science, cloud-scale performance, and AI capabilities [8][9] - The company aims to support clients through the entire drug development process, from discovery to commercialization, leveraging advancements in AI and cloud computing [6][8] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about the upcoming fiscal year, noting positive discussions with clients regarding budgeting and proposal activity [21] - The company anticipates that the overall market conditions will resemble those at the end of fiscal year 2025, with potential upside if biotech funding continues to improve [16][43] Other Important Information - The company ended the fiscal year with $32.4 million in cash and short-term investments, remaining well-capitalized with no debt [15][16] - Guidance for fiscal year 2026 includes total revenue between $79 million and $82 million, with year-over-year growth expected between 0% and 4% [16] Q&A Session Summary Question: Update on demand environment and trends - Management noted an uptick in biotech funding and positive budgeting activity for the upcoming year, although caution remains due to potential market surprises [21][22] Question: Feedback on GastroPlus release with AI capabilities - Initial responses to the AI-infused GastroPlus have been positive, with clients eager to leverage new functionalities [24][25] Question: Factors affecting large pharma spending - Management highlighted that large pharma's budgeting cycle is in place, with a cautiously optimistic outlook for increased spending in 2026 [31][32] Question: Guidance assumptions and renewal rates - The guidance assumes continued low to mid-80% renewal rates due to client consolidations and scrutiny of software configurations [70] Question: Pro-ficiency asset performance - Pro-ficiency software revenue declined by 63% in Q4, while service revenue from the acquisition grew by 70% [62][63]

Financial Data and Key Metrics Changes - Total revenue for the third quarter was $628 million, representing a 19% year-over-year increase and at the high end of guidance [9][19] - Non-GAAP operating income was $123 million, resulting in a 20% operating margin, an improvement from 19% in the previous year [23] - Net income for the quarter was $115 million, or $1.32 per share, compared to $98 million, or $1.16 per share, in the year-ago period [23] Business Line Data and Key Metrics Changes - Atlas revenue grew 30% year-over-year, now accounting for 75% of total revenue, up from 68% in the same quarter last year [19][22] - Non-Atlas revenue grew 8% year-over-year, reflecting consistent trends and expansion within the existing customer base [21] - The total customer count increased to over 62,500, with 2,600 new customers added in the quarter, marking a 65% growth in customer additions year-to-date [9][22] Market Data and Key Metrics Changes - Strong performance in Atlas was driven by large customers in the US and broad-based strength in EMEA [19] - The net annual recurring revenue (ARR) expansion rate increased to 120%, up from 119% in the previous quarter [20] Company Strategy and Development Direction - The company aims to become a foundational data platform for the AI era, leveraging its strengths in operational data and emerging AI workloads [6][10] - There is a focus on deepening customer relationships and advancing innovation to build a generational modern data platform [17] - The company is committed to strategic investments in engineering, marketing, and sales to drive growth [26][31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the continued momentum of Atlas and the strategic importance of the platform for customers [17][26] - The company raised its financial guidance for the fourth quarter and the full fiscal year 2026, reflecting strong performance and underlying fundamentals [17][29] - Management noted that while AI adoption is still early, there are encouraging signs of growth and demand for MongoDB's solutions [10][12] Other Important Information - The company ended the quarter with $2.3 billion in cash and cash equivalents, and operating cash flow was $144 million [24] - The company repurchased approximately 514,000 shares during the quarter under a $1 billion share repurchase authorization [24][28] Q&A Session Summary Question: What are the initial steps to make MongoDB a foundational data platform for the AI era? - Management highlighted the need for real-time operational data and the right context to support AI workloads, emphasizing the company's structural advantages [35][36] Question: How are the workloads for calendar year 2025 shaping up? - Management noted strength in larger customers and ongoing growth in existing workloads, indicating a positive outlook for future workloads [40] Question: What are the repeated themes in customer conversations? - Key themes include modernization efforts and the ongoing transformation to multi-cloud environments, with a focus on AI workloads [45][46] Question: How does the company plan to increase developer engagement? - The company is relaunching initiatives in the Bay Area to engage with AI-native companies and developers, aiming to increase mind share [72] Question: What is the philosophy around M&A for MongoDB? - Management expressed a preference for organic growth but remains open to strategic acquisitions that can accelerate the roadmap [82]

Financial Data and Key Metrics Changes - Revenue for fiscal year 2025 increased by 13% to $79.2 million, while total revenue for the fourth quarter decreased by 6% to $17.5 million [4][10] - Adjusted EBITDA grew by 8%, and adjusted EPS also increased by 8% for the fiscal year [4] - Total gross margin for the fiscal year was 58%, down from 62% in the prior year, with software gross margin decreasing from 84% to 79% [13][15] Business Line Data and Key Metrics Changes - Software revenue decreased by 9% in Q4, representing 52% of total revenue, while services revenue decreased by 3%, representing 48% [10] - For the fiscal year, software revenue increased by 12%, accounting for 58% of total revenue, and services revenue increased by 15%, accounting for 42% [10] - Specific product performance: Admet Predictor declined by 10% in Q4 but grew by 5% for the fiscal year; GastroPlus declined by 3% in Q4 but grew by 1% for the fiscal year; Monolith Suite grew by 3% in Q4 and 14% for the fiscal year [11] Market Data and Key Metrics Changes - The company noted early signs of stabilization in the market, with large pharma gaining clearer visibility into pricing frameworks and biotech funding improving modestly [5][6] - Proposal activity and conference engagement have strengthened, indicating a more confident budgeting cycle among clients [5] Company Strategy and Development Direction - The company completed a strategic reset in fiscal 2025, transitioning to a unified operating model that aligns product and technology with client-focused services [4] - The focus for fiscal 2026 includes enhancing biosimulation capabilities, integrating AI into workflows, and developing a connected ecosystem of products [8][9] - The company aims to support clients through discovery, clinical development, and commercialization with a modern, interoperable biosimulation ecosystem [8][9] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about the future, noting that while uncertainty persists, there are positive trends in biotech funding and client budgeting [5][6] - The company anticipates a stable operating environment for fiscal 2026, with guidance for total revenue between $79 million and $82 million, reflecting year-over-year growth of 0%-4% [16] Other Important Information - The company ended the fiscal year with $32.4 million in cash and short-term investments, remaining well-capitalized with no debt [15][16] - The effective tax rate for the fiscal year was 7%, with expectations for fiscal 2026 to be in the range of 12%-14% [15] Q&A Session Summary Question: Update on demand environment and trends - Management noted an uptick in biotech funding and positive discussions with clients regarding proposals and budgeting for the next year [21][22] Question: Feedback on GastroPlus release with AI capabilities - Initial responses to the AI-infused GastroPlus have been positive, with clients eager to leverage AI capabilities [24][25] Question: Factors affecting large pharma spending - Management indicated that while there are positive trends, caution remains due to individual client circumstances and the overall budgeting cycle [31][32] Question: Guidance assumptions and potential biotech recovery - The guidance assumes continued cautious optimism in biotech funding but does not project a significant uptick in revenue from this sector for 2026 [43][44] Question: Renewal rates and factors affecting them - Renewal rates have been impacted by client consolidations and budget scrutiny, but management expects improvement as clients have already reviewed their module needs [52][54] Question: Proficiency asset performance - Proficiency software revenue declined by 63% in Q4, while Med-Com services grew by 70%, indicating mixed performance post-acquisition [62][63] Question: Cash flow outlook and acquisition interest - Cash flow remains robust, and the company is actively looking for acquisition opportunities in biosimulation and clinical operations [72][73] Question: Pricing flexibility and plans for 2026 - The company plans to implement more aggressive pricing due to new AI capabilities, with expectations for a positive impact on renewal rates [76][77]

Credo Technology Group (NasdaqGS:CRDO) Q2 2026 Earnings Call December 01, 2025 05:00 PM ET Company ParticipantsThomas O'Malley - Equity Research DirectorDan Fleming - CFODan O'Neil - VP, Treasurer, Head and Investor RelationsJoseph Cardoso - VP and Equity ResearchQuinn Bolton - MD and Equity ResearchKarl Ackerman - MD, Semiconductors, Networking Hardware and Equity ResearchBill Brennan - President and CEOSuji Desilva - MD and Senior ResearchConference Call ParticipantsJay Rakesh - AnalystSebastian Nagy - An ...

MongoDB (NasdaqGM:MDB) Q3 2026 Earnings Call December 01, 2025 05:00 PM ET Company ParticipantsDev Ittycheria - Board MemberJess Lubert - VP of Investor RelationsSanjit Singh - Executive DirectorMike Berry - CFOCJ Desai - President and CEORaimo Lenschow - Managing DirectorBrad Reback - Managing DirectorMatt Martino - Vice PresidentConference Call ParticipantsKarl Keirstead - Managing Director and Software Equity Research AnalystAlex Zukin - Managing Director and Senior AnalystRyan MacWilliams - Software Equ ...

Financial Data and Key Metrics Changes - Revenue for fiscal year 2025 increased by 13% to $79.2 million, while total revenue for Q4 decreased by 6% to $17.5 million [10][11] - Adjusted EBITDA grew by 8%, and adjusted EPS also increased by 8% for the fiscal year [4] - Total gross margin for the fiscal year was 58%, down from 62% in the prior year, with software gross margin decreasing from 84% to 79% [14][16] Business Line Data and Key Metrics Changes - Software revenue for Q4 decreased by 9%, representing 52% of total revenue, while services revenue decreased by 3%, representing 48% of total revenue [10] - For the fiscal year, software revenue increased by 12%, representing 58% of total revenue, and services revenue increased by 15%, representing 42% of total revenue [10] - Discovery products contributed 18% to Q4 software revenue, while development products contributed 77% [10] Market Data and Key Metrics Changes - The company noted early signs of stabilization in the market, with large pharma gaining clearer visibility into pricing frameworks and biotech funding improving modestly [5] - Proposal activity and conference engagement have strengthened, indicating a more confident budgeting cycle among clients [5] Company Strategy and Development Direction - The company completed a strategic reset in 2025, transitioning to a unified operating model that aligns product and technology with client-focused services [4] - The focus is on building an integrated product ecosystem that combines validated science, cloud-scale performance, and AI capabilities [8][9] - The company aims to support clients through the entire drug development process, from discovery to commercialization, leveraging advancements in AI and cloud computing [6][18] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about the future, noting that while uncertainty persists, there are positive trends in biotech funding and client budgeting [5][18] - The company anticipates a stable operating environment for fiscal year 2026, with revenue guidance set between $79 million and $82 million [17] Other Important Information - The company ended the fiscal year with $32.4 million in cash and short-term investments, remaining well-capitalized with no debt [16] - The effective tax rate for the fiscal year was 7%, with expectations for 12%-14% in fiscal 2026 [16] Q&A Session Summary Question: Update on demand environment and trends affecting bookings and revenue - Management noted an uptick in biotech funding and positive discussions with clients regarding proposals and budgeting for the next year [21][23] Question: Feedback on the AI-infused GastroPlus release - Initial responses have been positive, with clients excited about the new capabilities and how they fit into their internal IT infrastructure [25][26] Question: Factors affecting large pharma spending and potential caution - Management highlighted that each client has unique challenges, but overall budgeting for 2026 appears positive [29][31] Question: Guidance details and underlying assumptions - No significant changes have occurred since the guidance was provided in October, with expectations for a stable revenue flow [36][38] Question: Renewal rates and factors affecting them - Renewal rates have been impacted by client consolidations and budget scrutiny, but management expects improvement as clients have already reviewed their needs [48][50] Question: Proficiency asset performance and revenue contributions - Proficiency software revenue was down 63% in Q4, while services revenue grew 70%, indicating a slowdown in clinical trial starts [55][56] Question: Cash flow outlook and acquisition interest - Cash flow remains robust, and the company is actively looking for acquisition opportunities in biosimulation and clinical operations [62][64] Question: Pricing flexibility and plans for the upcoming year - The company plans to implement more aggressive pricing due to new AI capabilities, but service side pricing will remain competitive [66][68]

Financial Data and Key Metrics Changes - Total revenue for Q3 2026 was $628 million, representing a 19% year-over-year increase and at the high end of guidance [7][17] - Non-GAAP operating income was $123 million, resulting in a 20% operating margin, an improvement from 19% in the previous year [20] - Net income for the quarter was $115 million, or $1.32 per share, compared to $98 million, or $1.16 per share, in the year-ago period [20] Business Line Data and Key Metrics Changes - Atlas revenue grew 30% year-over-year, up from 29% in Q2 and 26% in Q1, now representing 75% of total revenue [7][17] - Non-Atlas ARR grew 8% year-over-year, reflecting consistent trends in the non-Atlas business [18] - The total customer count increased to over 62,500, with 2,600 new customers added in the quarter, marking a 65% growth in customer additions year-to-date [7][19] Market Data and Key Metrics Changes - Strong performance was noted in the U.S. and broad-based strength in EMEA, driven by both new workloads and growth of existing workloads [17] - The net ARR expansion rate increased to 120% in Q3, up from 119% in the previous quarter [18] Company Strategy and Development Direction - The company aims to deepen customer relationships and advance its innovation agenda to build a generational modern data platform for the multi-cloud and AI era [15] - The focus is on expanding within existing accounts and penetrating the Fortune 500 market more effectively [78] - Strategic investments in engineering, marketing, and sales capacity are planned to drive continued growth [24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strong momentum of Atlas and the healthy fundamentals of the business, leading to raised financial guidance for Q4 and the full fiscal year 2026 [15][25] - The company is optimistic about the potential of AI workloads and the role MongoDB can play in supporting enterprises in their AI transformations [11][33] Other Important Information - The company ended the quarter with $2.3 billion in cash and cash equivalents, and operating cash flow was significantly above expectations at $144 million [20][21] - The company is executing a share buyback program to offset dilution from employee equity awards [24] Q&A Session Summary Question: What are the initial steps to make MongoDB a foundational data platform for the AI era? - Management highlighted the need for real-time operational data and the right context to support AI workloads, emphasizing the importance of MongoDB's capabilities in this area [32][34] Question: How are the workloads for calendar year 2025 shaping up? - Management noted strength in larger customers and ongoing growth in existing workloads, indicating a positive trend for future workloads [36][37] Question: What are the repeated themes in customer conversations? - Key themes include modernization efforts and the ongoing transformation to multi-cloud environments, with a focus on AI workloads [40][41] Question: What is driving the new customer strength within Atlas? - The engineering team's successful product launches and the self-serve team's efforts to reduce friction for onboarding new customers were cited as key factors [69][71] Question: How does management view M&A in relation to MongoDB? - Management expressed a preference for organic growth but remains open to strategic acquisitions that can accelerate the roadmap [73]